ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin
- PMID: 14586471
- DOI: 10.1038/nature02075
ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin
Abstract
Proteins contain thiol-bearing cysteine residues that are sensitive to oxidation, and this may interfere with biological function either as 'damage' or in the context of oxidant-dependent signal transduction. Cysteine thiols oxidized to sulphenic acid are generally unstable, either forming a disulphide with a nearby thiol or being further oxidized to a stable sulphinic acid. Cysteine-sulphenic acids and disulphides are known to be reduced by glutathione or thioredoxin in biological systems, but cysteine-sulphinic acid derivatives have been viewed as irreversible protein modifications. Here we identify a yeast protein of relative molecular mass M(r) = 13,000, which we have named sulphiredoxin (identified by the US spelling 'sulfiredoxin', in the Saccharomyces Genome Database), that is conserved in higher eukaryotes and reduces cysteine-sulphinic acid in the yeast peroxiredoxin Tsa1. Peroxiredoxins are ubiquitous thiol-containing antioxidants that reduce hydroperoxides and control hydroperoxide-mediated signalling in mammals. The reduction reaction catalysed by sulphiredoxin requires ATP hydrolysis and magnesium, involving a conserved active-site cysteine residue which forms a transient disulphide linkage with Tsa1. We propose that reduction of cysteine-sulphinic acids by sulphiredoxin involves activation by phosphorylation followed by a thiol-mediated reduction step. Sulphiredoxin is important for the antioxidant function of peroxiredoxins, and is likely to be involved in the repair of proteins containing cysteine-sulphinic acid modifications, and in signalling pathways involving protein oxidation.
Similar articles
-
The rate-limiting step of sulfiredoxin is associated with the transfer of the γ-phosphate of ATP to the sulfinic acid of overoxidized typical 2-Cys peroxiredoxins.FEBS Lett. 2011 Feb 4;585(3):574-8. doi: 10.1016/j.febslet.2011.01.012. Epub 2011 Jan 13. FEBS Lett. 2011. PMID: 21237158
-
Crystal structure of human peroxiredoxin 5, a novel type of mammalian peroxiredoxin at 1.5 A resolution.J Mol Biol. 2001 Aug 24;311(4):751-9. doi: 10.1006/jmbi.2001.4853. J Mol Biol. 2001. PMID: 11518528
-
Disulfide biochemistry in 2-cys peroxiredoxin: requirement of Glu50 and Arg146 for the reduction of yeast Tsa1 by thioredoxin.J Mol Biol. 2012 Nov 23;424(1-2):28-41. doi: 10.1016/j.jmb.2012.09.008. Epub 2012 Sep 15. J Mol Biol. 2012. PMID: 22985967
-
The sulfinic acid switch in proteins.Org Biomol Chem. 2004 Jul 21;2(14):1953-6. doi: 10.1039/b406180b. Epub 2004 Jun 29. Org Biomol Chem. 2004. PMID: 15254616 Review.
-
The plant multigenic family of thiol peroxidases.Free Radic Biol Med. 2005 Jun 1;38(11):1413-21. doi: 10.1016/j.freeradbiomed.2004.07.037. Free Radic Biol Med. 2005. PMID: 15890615 Review.
Cited by
-
Protein Oxidative Modifications in Neurodegenerative Diseases: From Advances in Detection and Modelling to Their Use as Disease Biomarkers.Antioxidants (Basel). 2024 May 31;13(6):681. doi: 10.3390/antiox13060681. Antioxidants (Basel). 2024. PMID: 38929122 Free PMC article. Review.
-
Altered Expression of Peroxiredoxins in Mouse Model of Progressive Myoclonus Epilepsy upon LPS-Induced Neuroinflammation.Antioxidants (Basel). 2021 Feb 27;10(3):357. doi: 10.3390/antiox10030357. Antioxidants (Basel). 2021. PMID: 33673502 Free PMC article.
-
The effects of neutrophil-generated hypochlorous acid and other hypohalous acids on host and pathogens.Cell Mol Life Sci. 2021 Jan;78(2):385-414. doi: 10.1007/s00018-020-03591-y. Epub 2020 Jul 13. Cell Mol Life Sci. 2021. PMID: 32661559 Free PMC article. Review.
-
Adaptive aneuploidy protects against thiol peroxidase deficiency by increasing respiration via key mitochondrial proteins.Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):10685-90. doi: 10.1073/pnas.1505315112. Epub 2015 Aug 10. Proc Natl Acad Sci U S A. 2015. PMID: 26261310 Free PMC article.
-
Sulfiredoxin: a potential therapeutic agent?Biomed Pharmacother. 2005 Aug;59(7):374-9. doi: 10.1016/j.biopha.2005.07.003. Biomed Pharmacother. 2005. PMID: 16102934 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials